The rationale for use of Ulipristal Acetate as first line in emergency contraception: Biological and clinical evidence

Gynecological Endocrinology

Volumn 30, Issue 10, 2014, Pages 688-690

  Glasier, Anna ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Availability cost; Efficacy; Emergency contraception; Safety; Ulipristal acetate

Indexed keywords

LEVONORGESTREL; ULIPRISTAL; CONTRACEPTIVE AGENT; PREGNANE DERIVATIVE;

ABDOMINAL PAIN; ARTICLE; BACKACHE; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; EMERGENCY CONTRACEPTION; FATIGUE; HEADACHE; HEMIANOPIA; HUMAN; HYDATIDIFORM MOLE; MENSTRUATION; NAUSEA; PREGNANCY; VAGINA BLEEDING; VIRUS INFECTION; FEMALE; PROCEDURES;

CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS; FEMALE; HUMANS; NORPREGNADIENES;

EID: 84907448883     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.950645     Document Type: Article

References (10)

1. Trussell J, Rodriguez G, Ellertson C. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 1998;57:363-9.
2. Creinin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108:1089-97.
3. Glasier A, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-Analysis. Lancet 2010; 375:555-62.
4. Croxatto HB, Brache V, Pavez M, et al. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception 2004;70:442-50.
5. Brache V, Cochon L, Jesam C, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod 2010;25:2256-63.
6. Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. Br Med J 2000;321:1259-62.
7. Brache V, Cochon L, Deniaud M, Croxatto H. Ulipristal acetate prevents ovulation more effectively than levonorgestrel - analysis of pooled data from three randomized trials of emergency contraception. Contraception 2013;88:611-8.
8. Levy DP, Jager M, Kapp N, Abitbol JL. Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women. Contraception 2014;89:431-3.
9. Hunter C, Ginde S, van Santen M, et al. Ulipristal Acetate 30 mg for emergency contraception is safe and effective both in adolescents and adult women: results from an International multicentre observational study. Free Communication 01.6. Eur J Contracept Reprod Health Care 2014;19:S67-90.
10. Thomas CM, Cameron S. Can we reduce costs and prevent more unintended pregnancies? A cost of illness and cost-effectiveness study comparing two methods of EHC. BMJ Open 2013;3: e003815.